Replies to post #42839 on Biotech Values

[DewDiligence]

> INSM – The comment of a single doctor is just that and not scientific proof.<

It’s not proof of anything, but it may be indicative of what many doctors think about the relative merit of the two products.

>Don't be surprised if you see someone go to jail over what just happened.<

Who? On what charges?

[ghmm]

Maybe someone with a better understanding of the Orphan Drug Law could explain this to me then. If Tercica had their product approved first shouldn't the only way Insmed's been approved was to offer an advantage over Tercica's? Unless for Orphan drug going from 2x to 1x dosing is considered enough? I thought they (Insmed) claimed other advantages too (whether real or not I can't say).